NCT06077994

Brief Summary

The primary objective of the current randomized controlled trial is to assess feasibility of integrating digital remote patient monitoring (dRPM) with the an enhanced Breathe Easy Pulmonary Rehabilitation Program for Individuals with COPD and Comorbidities (BEPR+), including aspects such as recruitment, retention, patient adherence, technology acceptability, adverse events, and staffing resources. The secondary objectives include comparing clinical outcomes (such as functional capacity, health status, quality of life, self-management, psychosocial health, physical activity and self-efficacy) between those who receive dRPM and BEPR+ (dRPM+) vs. those who receive BEPR+ alone.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
78

participants targeted

Target at P50-P75 for not_applicable chronic-obstructive-pulmonary-disease

Timeline
Completed

Started Sep 2023

Shorter than P25 for not_applicable chronic-obstructive-pulmonary-disease

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 28, 2023

Completed
Same day until next milestone

Study Start

First participant enrolled

September 28, 2023

Completed
13 days until next milestone

First Posted

Study publicly available on registry

October 11, 2023

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2024

Completed
Last Updated

September 8, 2025

Status Verified

September 1, 2025

Enrollment Period

10 months

First QC Date

September 28, 2023

Last Update Submit

September 4, 2025

Conditions

Keywords

COPDLung diseasesPulmonary RehabilitationDigital health

Outcome Measures

Primary Outcomes (3)

  • Feasibility of recruitment and participant retention

    A measure of the recruitment and retention of study participants

    18 months

  • Adherence

    adherence to vital sign monitoring during the 6 or 8 week pulmonary rehabilitation trial and the 12 week follow-up period.

    18 months

  • Acceptability

    Using a fit for purpose questionnaire to evaluate participant acceptance of the remote patient monitoring system.

    18 months

Secondary Outcomes (8)

  • Staffing time and resources

    18 months

  • Self-efficacy for managing chronic disease-6 items

    Baseline, post-program, and 12-week follow-up

  • Partners in Health Self-Management tool

    Baseline, post-program, and 12-week follow-up

  • Self-efficacy for exercise and physical activity

    Baseline, post-program, and 12-week follow-up

  • Physical activity levels

    Baseline, post-program, and 12-week follow-up

  • +3 more secondary outcomes

Study Arms (2)

Enhanced Breathe Easy Pulmonary Rehabilitation Program (BEPR+)

ACTIVE COMPARATOR

6 or 8 weeks BEPR+ program

Behavioral: Enhanced Breathe Easy Pulmonary Rehabilitation Program (BEPR+)

digital Remote Patient Monitoring + BEPR+ (dRPM+)

EXPERIMENTAL

6 or 8 weeks BEPR+; daily vitals readings (blood pressure, heart rate, oximetry, body temperature, and body weight) and an additional 12 weeks of dRPM reading once the BEPR+ program concludes

Behavioral: digital Remote Patient Monitoring+BEPR+ (dRPM+)

Interventions

In addition to the BEPR+ program as described, patients will use the Cloud Dx Connect Health System to take daily physiological readings (Blood pressure, heart rate, oximetry, body temperature and body weight). These data will be transmitted to a secured server supported by the provincial health care system. Participants and therapists will interact with these data in their respective dashboards and in conjunction with participants' determined medical action plan, engage in or make changes to participants current self-management regimens.

digital Remote Patient Monitoring + BEPR+ (dRPM+)

Patients will attend the BEPR+ program 3 days per week for 6 weeks or 2 days per week for 8 weeks (total of 16 sessions). Patients will receive 90 minutes of personalized and supervised exercise training (aerobic and resistance) and 60 minutes of education designed to promote self-management. Patients will also received one-on-one sessions with a therapist to review their medical action plan for exacerbation management, program and lifestyle goals (including physical activity), determine referral needs for other health services (i.e. smoking cessation, weight management, and psychological support). Patients will use an activity monitor for feedback and motivation for physical activity.

Enhanced Breathe Easy Pulmonary Rehabilitation Program (BEPR+)

Eligibility Criteria

Age30 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients must be enrolled into pulmonary rehabilitation at the G.F. MacDonald Centre for Lung Health with a diagnosis of chronic lung disease (COPD confirmed by post-bronchodilator forced expiratory volume in 1 second by forced vital capacity (FEV1/FVC) ratio of less than 0.7).
  • Patients must be able to read and communicate in English and willing and able to use digital devices.

You may not qualify if:

  • Patients with cognitive impairments who are unable to accurately complete questionnaires will also be excluded.
  • As part of standard rehabilitation referral procedures, all patients must be ambulatory and not have unstable cardiovascular disease.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

G. F. MacDonald Centre for Lung Health

Edmonton, Alberta, T5K 0L5, Canada

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic ObstructiveLung Diseases

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Michael K Stickland, PhD

    University of Alberta

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 28, 2023

First Posted

October 11, 2023

Study Start

September 28, 2023

Primary Completion

August 1, 2024

Study Completion

August 1, 2024

Last Updated

September 8, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations